Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 179472, 4 pages
http://dx.doi.org/10.1155/2015/179472
Case Report

Bilateral Adrenal Incidentalomas: A Rare Presentation of Lung Cancer

1Division of Endocrinology, Erciyes University Medical School, 38039 Kayseri, Turkey
2Department of Internal Diseases, Erciyes University Medical School, 38039 Kayseri, Turkey
3Division of Medical Oncology, Erciyes University Medical School, 38039 Kayseri, Turkey

Received 3 March 2015; Revised 15 May 2015; Accepted 17 May 2015

Academic Editor: Takeshi Usui

Copyright © 2015 Halit Diri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. F. Young Jr., “Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota,” Endocrinology and Metabolism Clinics of North America, vol. 29, no. 1, pp. 159–185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. W. F. Young Jr., “The incidentally discovered adrenal mass,” The New England Journal of Medicine, vol. 356, no. 6, pp. 601–610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Terzolo, A. Stigliano, I. Chiodini et al., “AME position statement on adrenal incidentaloma,” European Journal of Endocrinology, vol. 164, no. 6, pp. 851–870, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Cawood, P. J. Hunt, D. O'Shea, D. Cole, and S. Soule, “Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?” European Journal of Endocrinology, vol. 161, no. 4, pp. 513–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. H. Hamrahian, A. G. Ioachimescu, E. M. Remer et al., “Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland clinic experience,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 2, pp. 871–877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. H. Szolar, M. Korobkin, P. Reittner et al., “Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT,” Radiology, vol. 234, no. 2, pp. 479–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N. R. Dunnick, M. Korobkin, and I. Francis, “Adrenal radiology: distinguishing benign from malignant adrenal masses,” American Journal of Roentgenology, vol. 167, no. 4, pp. 861–867, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Angeli, G. Osella, A. Alì, and M. Terzolo, “Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group,” Hormone Research, vol. 47, no. 4–6, pp. 279–283, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Hammarstedt, A. Muth, B. Wängberg et al., “Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation,” Acta Radiologica, vol. 51, no. 10, pp. 1149–1156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. L. Porte, O. J. Ernst, T. Delebecq, D. Métois, L. G. Lemaitre, and A. J. Wurtz, “Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?” European Journal of Cardio-thoracic Surgery, vol. 15, no. 5, pp. 597–601, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Grumbach, B. M. K. Biller, G. D. Braunstein et al., “Management of the clinically inapparent adrenal mass (‘incidentaloma’),” Annals of Internal Medicine, vol. 138, no. 5, pp. 424–429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Lucchi, P. Dini, M. C. Ambrogi et al., “Metachronous adrenal masses in resected non-small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy,” European Journal of Cardio-Thoracic Surgery, vol. 27, no. 5, pp. 753–756, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. J. Quayle, J. A. Spitler, R. A. Pierce, T. C. Lairmore, J. F. Moley, and L. M. Brunt, “Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous,” Surgery, vol. 142, no. 4, pp. 497–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. J. Welch, P. E. Sheedy II, C. D. Johnson, C. M. Johnson, and D. H. Stephens, “CT-guided biopsy: prospective analysis of 1,000 procedures,” Radiology, vol. 171, no. 2, pp. 493–496, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Karanikiotis, A. A. Tentes, S. Markakidis, and K. Vafiadis, “Large bilateral adrenal metastases in non-small cell lung cancer,” World Journal of Surgical Oncology, vol. 2, article 37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mannelli, J. W. M. Lenders, K. Pacak, G. Parenti, and G. Eisenhofer, “Subclinical phaeochromocytoma,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 26, no. 4, pp. 507–515, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Marcus, E. J. Bergstralh, M. H. Zweig, A. Harris, K. P. Offord, and R. S. Fontana, “Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis,” Journal of the National Cancer Institute, vol. 98, no. 11, pp. 748–756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. Aberle, A. M. Adams, C. D. Berg et al., “Reduced lung-cancer mortality with low-dose computed tomographic screening,” The New England Journal of Medicine, vol. 365, no. 5, pp. 395–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. R. Church, W. C. Black, D. R. Aberle et al., “Results of initial low-dose computed tomographic screening for lung cancer,” The New England Journal of Medicine, vol. 368, no. 21, pp. 1980–1991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Brenner and E. J. Hall, “Computed tomography—an increasing source of radiation exposure,” The New England Journal of Medicine, vol. 357, no. 22, pp. 2277–2284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. A. M. van den Bergh, M. L. Essink-Bot, G. J. J. M. Borsboom, E. T. Scholten, R. J. van Klaveren, and H. J. de Koning, “Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial,” European Respiratory Journal, vol. 38, no. 1, pp. 154–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. T. Adler, E. Mack, and H. Chen, “Isolated adrenal mass in patients with a history of cancer: remember pheochromocytoma,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2358–2362, 2007. View at Publisher · View at Google Scholar · View at Scopus